NoribogaineAlternative Names: 12-hydroxy-ibogamine; 12-OH-ibogamine
Latest Information Update: 22 Dec 2016
At a glance
- Originator DemeRx
- Class Alkaloids; Analgesics; Small molecules
- Mechanism of Action NMDA receptor antagonists; Opioid receptor antagonists; Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Opioid abuse
Most Recent Events
- 28 Nov 2016 Noribogaine is still in phase I trials for Opioid abuse in New Zealand
- 18 May 2016 Chemical structure info added